ArticleThe international journal of cardiovascular imaging2026
Comprehensive multimodal imaging of quadricuspid pulmonary valves: morphology, function, and mid-term prognosis.
Article in The international journal of cardiovascular imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Quadricuspid pulmonary valve (QPV) is a rare congenital anomaly with limited reports. This study characterizes QPV morphology and function by multimodal imaging, evaluates predictors of moderate-to-severe pulmonary regurgitation (PR), and assesses mid-term prognosis. Retrospective search of the imaging database at a tertiary medical center identified patients diagnosed with QPV between October 2004 and September 2024. Multimodal imaging was utilized to assess the characteristics of QPV and associated abnormalities. Among 1,367,280 cardiac CT and MR exams, 16 patients were diagnosed with QPV (38% male; mean age 43.4 ± 19.7 years). The most common morphology was type D (38%, one larger, two equal intermediate, and one smaller cusps), with cusp fusion in 25% and Becker's type Ⅲ in 13%. Associated congenital heart disease (CHD) occurred in 6 patients (38%). Moderate-to-severe PR was observed in 11 patients (69%), severe pulmonary valve stenosis (PS) in one, and pulmonary artery aneurysm (PAA) in eight (50%). Both regurgitant orifice area (ROA) and main pulmonary artery (PA) dilation increased the risk of moderate-to-severe PR (OR = 2.33, p = 0.048; OR = 1.57, p = 0.041; each 0.25-unit increase). No significant difference was found between QPV classification and PR severity or clinical outcomes. During a median follow-up of 16 (IQR: 2-66) months, no deaths occurred, and 5 patients (31%) underwent surgery. QPV is a rare congenital cardiac malformation with diverse morphologies, predominantly associated with PR and PAA. Approximately one-third of patients required surgery. Multimodal imaging is essential for diagnosis, functional assessment, and management planning for QPV.
Indexed as
Identifiers
41714469What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.